文献速递慢性肾脏病

骨桥蛋白与慢性肾脏病患者肾功能及肾衰竭的关联:GCKD研究

Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

在德国慢性肾脏病(CKD)研究4950例患者中,中位随访6.5年期间发生471例肾衰竭和629例死亡;较高的骨桥蛋白(OPN)水平与估算肾小球滤过率(eGFR)降低、尿白蛋白与肌酐比值(UACR)升高、肾衰竭及全因死亡风险升高相关,6年后31%的肾衰竭事件可归因于较高的OPN水平。

要点

  • log(OPN)每升高1单位,eGFR低5.5 mL/min/1.73 m²(95%CI -6.4至-4.6)。
  • OPN每变化1%,UACR升高0.7%(估计效应0.7,95%CI 0.6-0.8)。
  • 较高OPN水平与肾衰竭(HR 1.4,95%CI 1.2-1.7)及全因死亡(HR 1.5,95%CI 1.3-1.8)风险升高相关。

核心结论

  • 较高的OPN水平与肾功能标志物恶化及不良结局风险升高相关,较大比例的肾衰竭可归因于较高的OPN水平,需进一步研究OPN在CKD进展中的作用及可能的治疗选择。

研究设计与样本

  • 德国慢性肾脏病(GCKD)研究参与者的基线血清样本中测量OPN。
  • 评估eGFR和UACR的横断面回归模型,以及全因死亡和肾衰竭的Cox回归模型,以估计OPN效应。
  • 此外评估OPN的预测能力和时间依赖性人群归因分数。

主要发现

  • 在4950例CKD患者中,中位随访6.5年期间发生471例肾衰竭事件和629例死亡。
  • log(OPN)每升高1单位与eGFR低5.5 mL/min/1.73 m²相关(95%CI -6.4至-4.6)。
  • OPN每变化1%与UACR升高0.7%相关(估计效应0.7,95%CI 0.6-0.8)。
  • 较高的OPN水平与较高的肾衰竭风险相关(HR 1.4,95%CI 1.2-1.7)及较高的全因死亡风险相关(HR 1.5,95%CI 1.3-1.8)。
  • 6年后,31%的肾衰竭事件可归因于较高的OPN水平(95%CI 3%-56%)。

局限性

  • 需进一步研究OPN在CKD进展中的作用及可能的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteopontin (OPN), synthesized in the thick ascending limb of Henle's loop and in the distal tubule, is involved in the pathogenesis of kidney fibrosis, a hallmark of kidney failure (KF). In a cohort of chronic kidney disease (CKD) patients, we evaluated OPN's association with kidney markers and KF. METHODS: OPN was measured from baseline serum samples of German Chronic Kidney Disease study participants. Cross-sectional regression models for estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR) as well as Cox regression models for all-cause mortality and KF were evaluated to estimate the OPN effect. Additionally, the predictive ability of OPN and time-dependent population-attributable fraction were evaluated. RESULTS: Over a median follow-up of 6.5 years, 471 KF events and 629 deaths occurred among 4950 CKD patients. One-unit higher log(OPN) was associated with 5.5 mL/min/1.73 m2 lower eGFR [95% confidence interval (95% CI) -6.4 to -4.6] and 1% change in OPN with 0.7% higher UACR (estimated effect 0.7, 95% CI 0.6-0.8). Moreover, higher OPN levels were associated with a higher risk of KF [hazard ratio (HR) 1.4, 95% CI 1.2-1.7] and all-cause mortality (HR 1.5, 95% CI 1.3-1.8). After 6 years, 31% of the KF events could be attributed to higher OPN levels (95% CI 3%-56%). CONCLUSIONS: In this study, higher OPN levels were associated with kidney function markers worsening and a higher risk for adverse outcomes. A larger proportion of KF could be attributed to higher OPN levels, warranting further research on OPN with regards to its role in CKD progression and possible treatment options.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Steinbrenner I, Sekula P, Kotsis F, et al. Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study. Nephrol Dial Transplant. 2023. PMID: 35524694. doi:10.1093/ndt/gfac173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。